Hypofractionated stereotactic radiotherapy for brain metastases larger than three centimeters
Centimeter
DOI:
10.3760/cma.j.issn.1004-4221.2009.03.176
Publication Date:
2012-12-01
AUTHORS (10)
ABSTRACT
Background: To evaluate the efficacy and outcomes of hypofractionated stereotactic radiotherapy (HSRT) for brain metastases > 3 cm.
SUPPLEMENTAL MATERIAL
Coming soon ....
REFERENCES ()
CITATIONS ()
EXTERNAL LINKS
PlumX Metrics
RECOMMENDATIONS
FAIR ASSESSMENT
Coming soon ....
JUPYTER LAB
Coming soon ....